449 related articles for article (PubMed ID: 25123936)
21. Effective determination method for a cyanobacterial neurotoxin, beta-N-methylamino-L-alanine.
Kubo T; Kato N; Hosoya K; Kaya K
Toxicon; 2008 Jun; 51(7):1264-8. PubMed ID: 18407310
[TBL] [Abstract][Full Text] [Related]
22. A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria blooms.
Caller TA; Doolin JW; Haney JF; Murby AJ; West KG; Farrar HE; Ball A; Harris BT; Stommel EW
Amyotroph Lateral Scler; 2009; 10 Suppl 2():101-8. PubMed ID: 19929741
[TBL] [Abstract][Full Text] [Related]
23. Elucidation of matrix effects and performance of solid-phase extraction for LC-MS/MS analysis of β-N-methylamino-L-alanine (BMAA) and 2,4-diaminobutyric acid (DAB) neurotoxins in cyanobacteria.
Li A; Fan H; Ma F; McCarron P; Thomas K; Tang X; Quilliam MA
Analyst; 2012 Mar; 137(5):1210-9. PubMed ID: 22249403
[TBL] [Abstract][Full Text] [Related]
24. Morphometric and neurochemical alterations found in l-BMAA treated rats.
de Munck E; Muñoz-Sáez E; Miguel BG; Solas MT; Martínez A; Arahuetes RM
Environ Toxicol Pharmacol; 2015 May; 39(3):1232-45. PubMed ID: 26002186
[TBL] [Abstract][Full Text] [Related]
25. Aerosolization of cyanobacteria as a risk factor for amyotrophic lateral sclerosis.
Stommel EW; Field NC; Caller TA
Med Hypotheses; 2013 Feb; 80(2):142-5. PubMed ID: 23246360
[TBL] [Abstract][Full Text] [Related]
26. A comparative study on three analytical methods for the determination of the neurotoxin BMAA in cyanobacteria.
Faassen EJ; Gillissen F; Lürling M
PLoS One; 2012; 7(5):e36667. PubMed ID: 22570736
[TBL] [Abstract][Full Text] [Related]
27. Possible therapy for ALS based on the cyanobacteria/BMAA hypothesis.
Bradley WG
Amyotroph Lateral Scler; 2009; 10 Suppl 2():118-23. PubMed ID: 19929743
[TBL] [Abstract][Full Text] [Related]
28. Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm.
Papapetropoulos S
Neurochem Int; 2007 Jun; 50(7-8):998-1003. PubMed ID: 17296249
[TBL] [Abstract][Full Text] [Related]
29. Cyanobacterial Neurotoxins: Their Occurrence and Mechanisms of Toxicity.
Rodgers KJ; Main BJ; Samardzic K
Neurotox Res; 2018 Jan; 33(1):168-177. PubMed ID: 28585115
[TBL] [Abstract][Full Text] [Related]
30. Determination of the neurotoxin BMAA (beta-N-methylamino-L-alanine) in cycad seed and cyanobacteria by LC-MS/MS (liquid chromatography tandem mass spectrometry).
Rosén J; Hellenäs KE
Analyst; 2008 Dec; 133(12):1785-9. PubMed ID: 19082084
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the neurotoxin β-N-methylamino-L-alanine (BMAA) and isomers in surface water by FMOC derivatization liquid chromatography high resolution mass spectrometry.
Vo Duy S; Munoz G; Dinh QT; Tien Do D; Simon DF; Sauvé S
PLoS One; 2019; 14(8):e0220698. PubMed ID: 31386693
[TBL] [Abstract][Full Text] [Related]
32. Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA.
Caller TA; Field NC; Chipman JW; Shi X; Harris BT; Stommel EW
Amyotroph Lateral Scler; 2012 Jan; 13(1):25-32. PubMed ID: 22214351
[TBL] [Abstract][Full Text] [Related]
33. Occurrence and transfer of a cyanobacterial neurotoxin β-methylamino-L-alanine within the aquatic food webs of Gonghu Bay (Lake Taihu, China) to evaluate the potential human health risk.
Jiao Y; Chen Q; Chen X; Wang X; Liao X; Jiang L; Wu J; Yang L
Sci Total Environ; 2014 Jan; 468-469():457-63. PubMed ID: 24055662
[TBL] [Abstract][Full Text] [Related]
34. Cyanobacteria, neurotoxins and water resources: are there implications for human neurodegenerative disease?
Metcalf JS; Codd GA
Amyotroph Lateral Scler; 2009; 10 Suppl 2():74-8. PubMed ID: 19929737
[TBL] [Abstract][Full Text] [Related]
35. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM
J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725
[TBL] [Abstract][Full Text] [Related]
36. β-N-methylamino-L-alanine (BMAA) uptake by the animal model, Daphnia magna and subsequent oxidative stress.
Esterhuizen-Londt M; Wiegand C; Downing TG
Toxicon; 2015 Jun; 100():20-6. PubMed ID: 25841344
[TBL] [Abstract][Full Text] [Related]
37. BMAA--an unusual cyanobacterial neurotoxin.
Vyas KJ; Weiss JH
Amyotroph Lateral Scler; 2009; 10 Suppl 2():50-5. PubMed ID: 19929732
[TBL] [Abstract][Full Text] [Related]
38. A Collaborative Evaluation of LC-MS/MS Based Methods for BMAA Analysis: Soluble Bound BMAA Found to Be an Important Fraction.
Faassen EJ; Antoniou MG; Beekman-Lukassen W; Blahova L; Chernova E; Christophoridis C; Combes A; Edwards C; Fastner J; Harmsen J; Hiskia A; Ilag LL; Kaloudis T; Lopicic S; Lürling M; Mazur-Marzec H; Meriluoto J; Porojan C; Viner-Mozzini Y; Zguna N
Mar Drugs; 2016 Feb; 14(3):. PubMed ID: 26938542
[TBL] [Abstract][Full Text] [Related]
39. The cyanobacterial neurotoxin β-N-methylamino-l-alanine (BMAA) induces neuronal and behavioral changes in honeybees.
Okle O; Rath L; Galizia CG; Dietrich DR
Toxicol Appl Pharmacol; 2013 Jul; 270(1):9-15. PubMed ID: 23591064
[TBL] [Abstract][Full Text] [Related]
40. The Effects of Long-term, Low-dose β-N-methylamino-L-alanine (BMAA) Exposures in Adult SOD
Weeks RD; Banack SA; Howell S; Thunga P; Metcalf JS; Green AJ; Cox PA; Planchart A
Neurotox Res; 2023 Oct; 41(5):481-495. PubMed ID: 37552461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
